{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Partial Response"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Complete Response"}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"}],"units":"Participants"}],"description":"Percentage of participants with germline deoxyribonucleic acid (DNA) repair mutation who experienced partial or complete response. Response was assessed by the Response Evaluation Criteria in Solid Tumors (RECIST) v1.1, and the Malignant Pleural Mesothelioma (MPM) criteria. Partial Response is at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum of diameters. Complete Response is disappearance of all target lesions.","groups":[{"description":"Participants With BRCA1 Associated Protein-1 (BAP1) Somatic Mutations","id":"OG000","title":"Comparison Group 2: Participants With BRCA1 Associated Protein-1 (BAP1) Somatic Mutations"}],"paramType":"NUMBER","populationDescription":"Per protocol, this outcome measure was only assessed in participants in Comparison Group 2.","reportingStatus":"POSTED","timeFrame":"6 months after enrollment of last patient","title":"Percentage of Participants With Breast Cancer Type 1 Associated Protein-1 (BAP1) Somatic Mutations Who Experienced Partial or Complete Response.","type":"PRIMARY","unitOfMeasure":"percentage of participants"}